Merck's oral PCSK9 inhibitor shows 55.8% LDL-C reduction in trial
Source: https://www.investing.com/news/company-news/mercks-oral-pcsk9-inhibitor-shows-558-ldlc-reduction-in-trial-93CH-4344327
About the Author
stocks news and daily news
